Diagnos Inc

About

Diagnos offers turn-key diabetic retinopathy screening programs. All screening projects are very flexible and are molded to each client’s individual needs.

Story

Diagnos offers anything from fully autonomous mobile screening units to just our telemedicine platform, and everything in between.

Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness around the world. It is a treatable disease that, as with most diseases, has a higher treatment success rate in its earlier stages. However, there are generally no symptoms until the disease has progressed to more severe stages, making early detection methods critical to helping prevent vision loss.

Diagnos has offices located in the UAE, Inida, Algeria, Poland, Mexico, the United States, and Canada.

Twitter: https://twitter.com/DiagnosInc

Mission

Preventing blindness through preventative screening

Impressum

CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care (POC) and comprises: image upload, image enhancement automated pre-screening, grading by a specialist, and referral to a specialist. CARA’s image enhancement algorithms make standard retinal images sharper, clearer, and easier to read. CARA is accessible securely over the Internet, and is compatible with all recognized image formats and brands of fundus cameras. CARA is a cost-effective tool for processing large numbers of images, in real-time and has been issued a licence by Health Canada for commercialization in Canada. CARA is also FDA, CE Mark, ISO 9001:2008, and ISO 13485:2003 approved.